Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Clinical trial NCT06615635 · RECRUITING

Trial details

NCT number: NCT06615635
Sponsor: Alpha Tau Medical LTD.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Squamous Cell Carcinoma Alpha Radiation Immunocompromised Carcinoma, Squamous Skin Cancer Brachytherapy

Start date: 2026-01-01
Primary completion: 2026-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.